Search - tctmd.com

Displaying 101 - 120 of 1867

Sort: Relevancy | Date

Presentation NY Valves 2025

Case Presentation: A Young Low-Risk Patient With Symptomatic Severe Tri-Leaflet Aortic Stenosis

Presenter: Robin Le Ruz

June 25, 2025

Presentation NY Valves 2025

Rationale and Status of “At Risk” Moderate AS Trials (PROGRESS and EXPAND TAVR II)

Presenter: Raj Makkar

June 25, 2025

Presentation NY Valves 2025

Perspectives From TAVR UNLOAD

Presenter: Nicolas M. Van Mieghem

June 25, 2025

Presentation NY Valves 2025

Do We Need Advanced Imaging to Phenotype Asymptomatic AS Patients? Lessons From the EVOLVED Trial

Presenter: Marc R. Dweck

June 25, 2025

Presentation NY Valves 2025

Not Much, We Need Stronger Evidence!

Presenter: Michael J. Mack

June 25, 2025

Presentation NY Valves 2025

Yes, Most Definitely!

Presenter: Philippe Genereux

June 25, 2025

Presentation NY Valves 2025

Managing AS Patients Before Symptoms or Severe Disease: Insights Into Current Practice

Presenter: Patrick T. O'Gara

June 25, 2025

News Daily News

Underexpanded Acurate Valves Come With Higher Stroke Risk, Study Confirms

Todd Neale

June 18, 2025

News Daily News

Dual Approach the Best Remedy for Aortic Stenosis, Amyloidosis: Registry

Caitlin E. Cox

June 09, 2025

News Daily News EuroPCR 2025

Underexpanded Acurate neo2 Valves Tied to Worse Outcomes: ACURATE IDE

Michael O'Riordan

May 28, 2025

News Conference News EuroPCR 2025

Stroke Risk Higher With TAVI vs Surgery at 5 Years: UK TAVI

Michael O'Riordan

May 23, 2025

News Conference News EuroPCR 2025

Lower MACE Risk With FFR- vs Angio-Guided PCI in AS Patients: FAITAVI

L.A. McKeown

May 22, 2025

News Conference News EuroPCR 2025

Higher Mortality With TAVI Over Surgery in Bicuspid Aortic Stenosis

Michael O'Riordan

May 22, 2025

Presentation EuroPCR 2025

Surgical versus percutaneous treatment of bicuspid aortic stenosis: a propensity score analysis

Presenter: Pierre Deharo

May 22, 2025

News Conference News EuroPCR 2025

Myval Noninferior to Other THVs at 1 Year, but Questions Persist

L.A. McKeown

May 21, 2025

News Conference News EuroPCR 2025

Early TAVI Improves Prognosis in Asymptomatic AS No Matter the Extent of Cardiac Damage

Yael L. Maxwell

May 21, 2025

News Conference News ESC Heart Failure 2025

No Additional Gain in Quality of Life With Dapagliflozin on Top of TAVI

Todd Neale

May 20, 2025

News Daily News

Registry Data Rekindle Talk Over the Best Valve for TAVI in Small Annuli

Caitlin E. Cox

May 19, 2025

News Daily News

Four-Dimensional Flow CMR Shows Promise in Aortic Stenosis

Yael L. Maxwell

May 13, 2025

News Conference News SCAI 2025

Benefits of TAVI Before Symptom Onset Not Hindered by Age: EARLY TAVR

L.A. McKeown

May 02, 2025

Advertisement

Case Presentation: A Young Low-Risk Patient With Symptomatic Severe Tri-Leaflet Aortic Stenosis

Rationale and Status of “At Risk” Moderate AS Trials (PROGRESS and EXPAND TAVR II)

Perspectives From TAVR UNLOAD

Do We Need Advanced Imaging to Phenotype Asymptomatic AS Patients? Lessons From the EVOLVED Trial

Not Much, We Need Stronger Evidence!

Yes, Most Definitely!

Managing AS Patients Before Symptoms or Severe Disease: Insights Into Current Practice

Underexpanded Acurate Valves Come With Higher Stroke Risk, Study Confirms

Dual Approach the Best Remedy for Aortic Stenosis, Amyloidosis: Registry

Underexpanded Acurate neo2 Valves Tied to Worse Outcomes: ACURATE IDE

Stroke Risk Higher With TAVI vs Surgery at 5 Years: UK TAVI

Lower MACE Risk With FFR- vs Angio-Guided PCI in AS Patients: FAITAVI

Higher Mortality With TAVI Over Surgery in Bicuspid Aortic Stenosis

Surgical versus percutaneous treatment of bicuspid aortic stenosis: a propensity score analysis

Myval Noninferior to Other THVs at 1 Year, but Questions Persist

Early TAVI Improves Prognosis in Asymptomatic AS No Matter the Extent of Cardiac Damage

No Additional Gain in Quality of Life With Dapagliflozin on Top of TAVI

Registry Data Rekindle Talk Over the Best Valve for TAVI in Small Annuli

Four-Dimensional Flow CMR Shows Promise in Aortic Stenosis

Benefits of TAVI Before Symptom Onset Not Hindered by Age: EARLY TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content